(Q51742202)

English

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.

scientific article published in February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

type 2 diabetes

1 reference

based on heuristic

inferred from title

3

object named as

Hisashi Adachi

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

author name string

Kazuo Nakamura

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Sho-ichi Yamagishi

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Takanori Matsui

4

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Yayoi Kurita-Nakamura

5

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Masayoshi Takeuchi

6

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Hiroyoshi Inoue

7

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Tsutomu Imaizumi

8

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

publication date

1 February 2008

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

24

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

109-114

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

21 January 2018

Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

21 January 2018

Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced protein glycosylation in diabetes and aging

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherosclerosis and diabetes: the RAGE connection

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.766

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.766

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17694504

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51742202&oldid=2076142422"